NewAmsterdam Pharma Co N.V. Annual Share-based Payment Arrangement, Expense in USD from 2021 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
NewAmsterdam Pharma Co N.V. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2021 to 2023.
  • NewAmsterdam Pharma Co N.V. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $8.29M, a 49.2% increase year-over-year.
  • NewAmsterdam Pharma Co N.V. annual Share-based Payment Arrangement, Expense for 2023 was $24.6M, a 488% increase from 2022.
  • NewAmsterdam Pharma Co N.V. annual Share-based Payment Arrangement, Expense for 2022 was $4.18M, a 245% increase from 2021.
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $24.6M +$20.4M +488% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 $4.18M +$2.97M +245% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 $1.21M Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.